Recio-Poveda, Lucía

	Rights	Preview	Issue Date	Title	Author(s)	Type
1	openAccess		28-Jan-2016	Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia	Zarrabeitia, Roberto; Ojeda-Fernández, María Luisa ; Recio-Poveda, Lucía ; Bernabéu, Carmelo  ; Parra, José A.; Albiñana, Virginia ; Botella, Luisa María	artículo
2	openAccess		25-Nov-2013	Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1	Fontalba, Ana; Fernández-Luna, Jose L.; Zarrabeitia, Roberto; Recio-Poveda, Lucía ; Albiñana, Virginia ; Ojeda-Fernández, María Luisa ; Bernabéu, Carmelo  ; Alcaraz, Luis A.; Botella, Luisa María	artículo
3	openAccess		28-May-2019	Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial	González-Rodríguez, Beatriz; Villar Gómez de las Heras, Karina; Aguirre, Daniel T.; Rodriguez-Padial, Luis; Albiñana, Virginia ; Recio-Poveda, Lucía ; Cuesta, Ángel M. ; Botella, Luisa María  ; Jiménez Escribano, Rosa María	artículo
4	closedAccess		1-May-2011	Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells	Albiñana, Virginia ; Sanz-Rodriguez, Francisco; Recio-Poveda, Lucía ; Bernabéu, Carmelo  ; Botella, Luisa María	artículo
5	openAccess		24-Mar-2016	Mice lacking endoglin in macrophages show an impaired immune response	Ojeda-Fernández, María Luisa ; Recio-Poveda, Lucía ; Aristorena, Mikel; Lastres, Pedro  ; Blanco, Francisco J.  ; Gallardo-Vara, Eunate ; Casas-Engel, Mateo de las ; Corbí, Angel L.  ; Bernabéu, Carmelo  ; Botella, Luisa María	artículo
6	openAccess		26-Jun-2013	MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells	Tabruyn, Sebastien P.; Hansen, Sylvain; Ojeda-Fernández, María Luisa ; Bovy, Nicolas; Zarrabeitia, Roberto; Recio-Poveda, Lucía ; Bernabéu, Carmelo  ; Martial, Joseph A.; Botella, Luisa María  ; Struman, Ingrid	artículo
7	openAccess		23-Feb-2017	Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1	Albiñana, Virginia ; Zafra, M. Paz; Colau, Jorge; Zarrabeitia, Roberto; Recio-Poveda, Lucía ; Olavarrieta, Leticia; Pérez-Pérez, Julián; Botella, Luisa María	artículo
8	openAccess		3-May-2012	Propranolol as an antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia	Albiñana, Virginia ; Recio-Poveda, Lucía ; Zarrabeitia, Roberto; Bernabéu, Carmelo  ; Botella, Luisa María	artículo
9	closedAccess		Apr-2010	Reduced plasma levels of Ang-2 and sEng as novel biomarkers in Hereditary Hemorrhagic Telangiectasia (HHT)	Ojeda-Fernández, María Luisa ; Barrios, Laura ; Rodríguez-Barbero, Alicia; Recio-Poveda, Lucía ; Bernabéu, Carmelo  ; Botella, Luisa María	artículo
10			29-Jun-2017	Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease	Albiñana, Virginia ; Jiménez Escribano, Rosa María; Soler, Isabel; Rodríguez Padial, Luis; Recio-Poveda, Lucía ; Villar Gómez de las Heras, Karina; Botella, Luisa María	artículo
11	openAccess		31-Mar-2015	Research on potential biomarkers in hereditary hemorrhagic telangiectasia	Botella, Luisa María  ; Albiñana, Virginia ; Ojeda-Fernández, María Luisa ; Recio-Poveda, Lucía ; Bernabéu, Carmelo	artículo
12	openAccess		2020	Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding	Albiñana, Virginia ; Cuesta, Ángel M. ; Rojas-P, Isabel de; Gallardo-Vara; Recio-Poveda, Lucía ; Bernabéu, Carmelo  ; Botella, Luisa María	artículo
13	openAccess		25-Aug-2020	Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from Von Hippel–Lindau disease	Albiñana, Virginia ; Gallardo-Vara, Eunate ; Rojas-P, Isabel de; Recio-Poveda, Lucía ; Aguado, Tania; Canto-Cano, Ana; Aguirre, Daniel T.; Serra, Marcelo M.; González-Peramato, Pilar; Martínez-Piñeiro, Luis; Cuesta, Ángel M. ; Botella, Luisa María	artículo
14	openAccess		11-Jul-2019	The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease	Cuesta, Ángel M. ; Albiñana, Virginia ; Gallardo-Vara, Eunate ; Recio-Poveda, Lucía ; I. de Rojas-P; Villar Gómez de las Heras, Karina; Aguirre, Daniel T.; Botella, Luisa María	artículo
15	openAccess		2019	Topically applied etamsylate: a new orphan drugfor HHT-derived epistaxis (antiangiogenesisthrough FGF pathway inhibition)	Albiñana, Virginia ; Giménez-Gallego, Guillermo ; García-Mato, Ángela; Palacios, Patricia; Recio-Poveda, Lucía ; Cuesta, Ángel M. ; Patier, José-Luis; Botella, Luisa María	artículo